Benefit Analysis of Postoperative Adjuvant Therapy in Esophageal Squamous Cell Carcinoma Patients with Non-pCR or Non-MPR
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e65
DOI: 10.1016/j.ijrobp.2026.06.796 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von L. Liu und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liu, L., Wang, L., Han, C., & Zhu, S. (2026). Benefit Analysis of Postoperative Adjuvant Therapy in Esophageal Squamous Cell Carcinoma Patients with Non-pCR or Non-MPR. International Journal of Radiation Oncology*Biology*Physics, 126(1), e65. https://doi.org/10.1016/j.ijrobp.2026.06.796
Vancouver
Liu L, Wang L, Han C, Zhu S. Benefit Analysis of Postoperative Adjuvant Therapy in Esophageal Squamous Cell Carcinoma Patients with Non-pCR or Non-MPR. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e65. doi:10.1016/j.ijrobp.2026.06.796
BibTeX
@article{Liu2026,
author = {Liu, L. and Wang, L. and Han, C. and Zhu, S.},
title = {Benefit Analysis of Postoperative Adjuvant Therapy in Esophageal Squamous Cell Carcinoma Patients with Non-pCR or Non-MPR},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e65},
doi = {10.1016/j.ijrobp.2026.06.796}
}
EUVIMED